UCLA Health tests 3D-printed COVID-19 swabs to ensure supply source

LabPulse.com staff writers
Jun 9, 2020
2020 06 10 19 35 3549 Ucla Lattice Swab 400

The University of California, Los Angeles (UCLA) Health has tested new 3D-printed swabs that can be used for COVID-19 screening.

The swabs look like common cotton swabs except they are made with sterile, spongy materials and the shafts are longer. Each consists of a single plastic material with a lattice design at the end for sample collection.

UCLA Health's 3D-printed swabs used to test for COVID-19 have longer shafts and are made of sterile, spongy materials. Image courtesy of UCLA Health.UCLA Health's 3D-printed swabs used to test for COVID-19 have longer shafts and are made of sterile, spongy materials. Image courtesy of UCLA Health.

The new swabs help address the shortage of testing supplies during the coronavirus pandemic. UCLA believes that they can be manufactured quickly and in large quantities, ensuring a secure source of supplies across its health system.

Latest in Infectious
Earning Stock Market Social
Asep Medical Holdings aims for Nasdaq listing
May 31, 2023
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
May 11, 2023
Business Regulation Graphic Social Resized
Eurobio Scientific obtains IVDR CE markings for PCR tests
May 24, 2023
Kidneys Social
Renalytix selects Eversana to expand commercialization of KidneyIntelX test for diabetic kidney disease
May 25, 2023
Related Stories
2021 06 08 21 44 7484 Cancer Cell Yellow 400
Pathology, histology
Deepcell, UCLA pathologist collaborate on cancer research
2020 01 22 00 12 9591 Liver Cancer 400
Hepatocellular Carcinoma
Liver cancer diagnostic test offers promise of early detection
2019 11 18 18 47 0274 3 D Printing2 400
510(k)
Structo to produce nasal testing swabs
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Infectious
Asep Medical Holdings aims for Nasdaq listing
Sepset Biosciences, an Asep Medical business, is preparing for clinical studies aimed at the commercialization of a diagnostic test. The test leverages gene expression to predict the development of severe sepsis.
May 31, 2023
Earning Stock Market Social
Malaria rapid tests in study show low performance for travelers to China
The study evaluated the sensitivity of four parasite enzyme lactate dehydrogenase-targeting RDTs and one aldolase-targeting RDT for P. malariae detection.
May 25, 2023
Blood Test Samples Lab Social
Eurobio Scientific obtains IVDR CE markings for PCR tests
The CE markings enable the firm to market three of its PCR tests as class C in vitro diagnostic medical devices for the detection of infectious diseases.
May 24, 2023
Business Regulation Graphic Social Resized
Renalytix selects Eversana to expand commercialization of KidneyIntelX test for diabetic kidney disease
The commercialization model developed by the two companies will be launched to primary care providers in parts of the U.S. later in the summer.
May 25, 2023
Kidneys Social
Validation data presented for Cytovale sepsis diagnostic test
The lead investigator has presented the results of a study to validate a rapid diagnostic test that detects sepsis in the emergency department. The study data were used to obtain FDA clearance for the test last December.
May 24, 2023
Diagnose Sepsis Social
Medical records link vaccination against COVID-19 to reduced risk of non-respiratory symptoms
An analysis, details of which were presented Tuesday at the ATS 2023 International Conference in Washington, DC, reviewed data from 63,454 patients who were treated in a University of California medical center for COVID-19.
May 23, 2023
Covid 19 Vaccine Distribution Transport Social
T2 Biosystems submits FDA 510(k) premarket notification for biothreat panel
The panel is a fully-automated, direct-from-blood test designed to run on the T2 Biosystem’s FDA-cleared T2Dx Instrument and simultaneously detects six pathogens identified as threats by the CDC.
May 23, 2023
Fda Button Social
Industry organizations urge Congress to protect access to laboratory tests
In a letter to Congress, provider organizations make the case that without congressional action, Medicare reimbursement cuts could jeopardize access to many clinical laboratory tests.
May 22, 2023
Business Men Handshake Social
Beckman Coulter analyzer developed 'from the ground up' to address IVD industry constraints
At a time of scarce resources, the system requires no daily maintenance and only 10 minutes weekly and monthly maintenance, said Dr. Pamela Christudoss of Christian Medical College, who evaluated the analyzer prior to its broad launch last week.
May 23, 2023
Dx I 9000 Analyzer Sample Rack Social
Hologic obtains FDA clearance for multiplex SARS-CoV-2/Flu A/Flu B/RSV assay
The Panther Fusion SARS-CoV-2/Flu A/B/RSV assay runs on the fully automated, high-throughput Panther Fusion system, which provides initial results in approximately three hours and can process more than 1,000 tests in 24 hours.
May 19, 2023
Hologic 0807 Social
Masking should continue in healthcare settings, some experts say
Masking in healthcare settings should continue in order to optimize patient safety, recommend infectious disease experts in a commentary.
May 16, 2023
Doctors Masks Team Social
FDA clears Becton Dickinson MRSA imaging software
The software leverages AI to automate the traditionally labor- and time-intensive task of inspecting Petri dishes to determine whether there is bacterial growth.
May 16, 2023
Bd Kiestra Mrsa Imaging Social
Page 1 of 144
Next Page